학술논문
'학술논문'
에서 검색결과 1,121건 | 목록
1~10
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
Academic Journal
Marchand, T; Pastoret, C; Damaj, G; Lebouvier, A; Herbaux, C; Moignet, A; Pavlosky, M; Pavlosky, A; Blouet, A; Eloit, M; Launay, V; Lebreton, P; Stamatoullas, A; Nilsson, C; Ochmann, M; Prola, J; Lamy, T
British journal of haematology.
Academic Journal
Ito, Y; Marouf, A; Kogure, Y; Koya, J; Lievin, R; Bruneau, J; Tabata, M; Saito, Y; Shingaki, S; Yuasa, M; Yamaguchi, K; Murakami, K; Weil, R; Vavasseur, M; Andrieu, GP; Latiri, M; Veleanu, L; Dussiot, M; Andre, I; Joshi, A; Lagresle-Peyrou, C; Magerus, A; Chaubard, S; Lavergne, D; Bachy, E; Brunet, E; Fataccioli, V; Brouzes, C; Laurent, C; de Leval, L; Traverse-Glehen, A; Bossard, C; Parrens, M; Meignin, V; Philippe, L; Rossignol, J; Suarez, F; Michot, JM; Tournilhac, O; Damaj, G; Lemonnier, F; Bole-Feysot, C; Nitschke, P; Tesson, B; Molina, T; Asnafi, V; Watatani, Y; Chiba, K; Okada, A; Shiraishi, Y; Tsukita, S; Izutsu, K; Miyoshi, H; Ohshima, K; Sakata, S; Dobashi, A; Takeuchi, K; Sanada, M; Gaulard, P; Jaccard, A; Ogawa, S; Hermine, O; Kataoka, K; Couronne, L
CANCER RESEARCH. 84(13):2181-2201
Academic Journal
Cheson, BD; Brugger, W; Damaj, G; Dreyling, M; Kahl, B; Kimby, E; Ogura, M; Weidmann, E; Wendtner, CM; Zinzani, PL
Leukemia & lymphoma. 57(4):766-782
Conference
2017 9th IEEE-GCC Conference and Exhibition (GCCCE) IEEE-GCC Conference and Exhibition (GCCCE), 2017 9th. :1-9 May, 2017
Academic Journal
Lefrère, F; Zohar, S; Ghez, D; Delarue, R; Audat, F; Suarez, F; Hermine, O; Damaj, G; Maillard, N; Ribeil, J A; Azagury, M; Misbahi, R; Jondeau, K; Cavazzana-Calvo, M; Dal Cortivo, L; Varet, B
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 37(8):725-729
Academic Journal
In Cancer Epidemiology February 2023 82
Academic Journal
Tournilhac O; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Altmann B; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Friedrichs B; Department of Medicine A, University Hospital Muenster, Muenster, Germany.; Bouabdallah K; Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France.; Leclerc M; Service d'Hématologie Clinique, Hôpital Henri Mondor, Hôpitaux de Paris, Créteil, France.; Cartron G; Departement Hématologie Clinique, CHU de Montpellier, Montpellier, France.; Turlure P; Service d'Hématologie Clinique, CHU Dupuytren, Limoges, France.; Reimer P; Department of Hematology, Oncology and Stem Cell Transplantation, Evang. Kliniken Essen-Mitte, Essen, Germany.; Wagner-Drouet E; University Medicine III Mainz, Mainz, Germany.; Sanhes L; Service d'Hématologie Clinique, CH Saint-Jean, Perpignan, France.; Houot R; Hematology Department, Rennes University Hospital, INSERM Research Unit 1236, Rennes, France.; Roussel M; Service d'Hématologie Clinique, CHU Dupuytren, Limoges, France.; Service d'Hématologie, IUCT-Oncopole, Toulouse, France.; Kroschinsky F; Medizinische Klinik I, University Hospital Dresden, Dresden, Germany.; Dreger P; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Viardot A; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; de Leval L; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Rosenwald A; Department of Pathology, University of Wuerzburg and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany.; Gaulard P; Department of Pathology, University Hospital Henri Mondor, University Paris-Est Créteil, Inserm U955, Créteil, France.; Wulf G; Department of Hematology and Oncology, Georg August University, Goettingen, Germany.; Villate A; Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours, France.; Latiere C; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Elmaagacli A; Department of Hematology and Stem Cell Transplantation, Asklepios-Klinik St Georg, Hamburg, Germany.; Glass B; Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany.; Poeschel V; Department of Internal Medicine 1, Saarland University Medical School, Homburg/Saar, Germany.; Damaj G; Hematology Institute, University Hospital, Normandy University, Caen, France.; Sibon D; Department of Hematology, Necker University Hospital, University-Sorbonne Paris Cite, Paris, France.; Durot E; Service d'Hématologie Clinique, Centre Hospitalier Universitaire, Hopital Robert Debré, Reims, France.; Bilger K; Hematology Department, CHU, Strasbourg, France.; Banos A; Department of Hematology, Centre Hospitalier de la Cote de Basque, Bayonne, France.; Haenel M; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany.; Dreyling M; Department of Medicine III, Ludwig-Maximilians-University, Muenchen, Germany.; Keller U; Clinic and Policlinic for Internal Medicine III, School of Medicine, Technical University Munich, Munich, Germany.; Tiab M; Centre Hospitalier Départemental, La Roche Sur Yon, France.; Drenou B; Service d'Hématologie Clinique GHRMSA, Mulhouse, France.; Cornillon J; Service d'Hématologie et thérapie cellulaire, CHU de Saint Etienne, France.; Nguyen S; Clinical Hematology Unit, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.; Robin M; Institut d'Hématologie, Hospital Saint Louis Paris, APHP, Paris, France.; Nickelsen M; Onkologie Lerchenfeld, Hamburg, Germany.; Trümper L; Department of Hematology and Oncology, Georg August University, Goettingen, Germany.; Lenz G; Department of Medicine A, University Hospital Muenster, Muenster, Germany.; Ziepert M; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Schmitz N; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Camus V; Centre Henri Becquerel, Rouen, France.; Houot R; CHU Rennes, University of Rennes, Rennes, France.; Brisou G; Institut Paoli Calmettes, Marseille, France.; Tessoulin B; Nantes University Hospital, Nantes, France.; Bailly S; CHU Clermont-Ferrand, Clermont-Ferrand, France.; Sesques P; CHU Lyon Sud, HCL, Pierre Bénite, France.; Decroocq J; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, F-75014 Paris, France, Paris, France.; Krzisch D; APHP, Hopital Saint Louis, Paris, France.; Obéric L; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.; Lemonnier F; Hôpital Henri Mondor, Créteil, France.; Bouabdallah K; Service d'Hématologie clinique et Thérapie cellulaire, PESSAC, France.; Campidelli A; CHRU Nancy, Vandoeuvre-les-Nancy, France.; Tounes L; Hopital Saint Antoine, Paris, France.; Abraham J; CHU Limoges, Limoges, France.; Herbaux C; CHU Montpellier UMR5535, Montpellier, France.; Morschhauser F; University of Lille, Lille, France.; Damaj G; Normandy University, Hematology Institute, Caen, France.; Guidez S; CHU Poitiers, Poitiers, France.; Carras S; University Hospital Grenoble-Alpes, Grenoble, France.; Fornecker LM; Institut de Cancérologie Strasbourg Europe, STRASBOURG, France.; Choquet S; Groupe Hospitalier Pitié Salpétrière, APHP, Sorbonne Université, Paris, France.; Hermine O; INSERM U1163 CNRS ERL8254 Imagine Institute, Paris, France.; Paillassa J; CHU d'Angers, Angers, France.; Chauchet A; CHU, Besancon, France.; Casasnovas O; C.H.U Dijon Bourgogne, Dijon, France.; Drieu La Rochelle L; CHU de Tours, tours, France.; Castilla-Llorente C; Gustave Roussy Cancer Campus, Villejuif, France.; Joris M; CHU Amiens, Amiens, France.; Dupont V; LYSARC, Pierre Bénite, France.; Marquet A; LYSARC, Pierre Bénite, France.; Le Gouill S; Institut Curie, Paris, France.; Jardin F; Centre Henri Becquerel, rouen, France.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Lefèvre G; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO). Electronic address: guillaume.lefevre@chu-lille.fr.; Gibier JB; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Bongiovanni A; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France.; Lhermitte L; Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Rossignol J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Anglo E; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France.; Dendooven A; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France.; Dubois R; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Terriou L; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France.; Launay D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France.; Barete S; CEREMAST, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Unit de Dermatologie, Sorbonne Université Paris, Paris, France.; Esnault S; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wis.; Frenzel L; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Gourguechon C; Department of Hematology, CHU Amiens, Amiens, France.; Ballul T; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Dezoteux F; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France.; Staumont-Salle D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France.; Copin MC; Department of Pathology, CHU Angers, University of Angers, INSERM, CNRS, CRCI(2)NA, Angers, France.; Rignault-Bricard R; University of Paris, Institut Imagine, INSERM, Paris, France.; Maciel TT; University of Paris, Institut Imagine, INSERM, Paris, France.; Damaj G; Institut d'Hématologie, University of Caen Normandie, Caen, France.; Tardivel M; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France.; Crinquette-Verhasselt M; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France.; Dubreuil P; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France.; Maouche-Chrétien L; University of Paris, Institut Imagine, INSERM, Paris, France.; Bruneau J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Pathology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Lortholary O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France.; Duployez N; CNRS, INSERM, CHU Lille, Cancer Heterogeneity, Plasticity, and Resistance to Therapies (CANTHER), University of Lille, Institut d'Hématologie, CHU Lille, Lille, France.; Behal H; University of Lille, CHU Lille, Evaluation des Technologies de Santé et des Pratiques Médicales (METRICS), Lille, France.; Molina TJ; University of Paris, Institut Imagine, INSERM, Paris, France; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France.; Hermine O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France. Electronic address: olivier.hermine@aphp.fr.
Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
Academic Journal
In: EJNMMI Research . (EJNMMI Research, 1 December 2019, 9(1))
검색 결과 제한하기
제한된 항목
[검색어] Damaj, G.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어